Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Biotech/Pharma - Investor
Derma Sciences, Inc. (DSCI) CEO Discusses Continued Growth Of MEDIHONEY® At Comvita Annual Meeting of Shareholders 7/25/2014 9:08:59 AM
Arena Pharmaceuticals, Inc. (ARNA) To Host Corporate Update And Financial Results Conference Call And Webcast On Friday, August 1 7/25/2014 9:00:22 AM
PerkinElmer, Inc. (PKI) Board Declares Quarterly Dividend 7/25/2014 8:52:54 AM
PTC Therapeutics, Inc. (PTCT) To Host Conference Call To Discuss Second Quarter 2014 Financial Results 7/25/2014 8:44:55 AM
Asterias Biotherapeutics Announces Live Investor Webcast 7/25/2014 8:08:28 AM
Major Restructure At Allergan Inc. (AGN) Amid Valeant Pharmaceuticals International (VRX) Takeover Battle; Allergan Inc. To Cut 1,500 Jobs 7/21/2014 7:13:31 AM
Seattle Biotech Immune Design Corporation (IMDZ) Prices IPO At $12 Per Share, The Low End Of The Range 7/24/2014 9:06:27 AM
San Diego Biotech Pfenex Inc. (PFNX) Prices IPO At $6 Per Share, Below Downwardly Revised $8 Expectation 7/24/2014 8:06:21 AM
Merck & Co., Inc. (MRK) Announces Fourth-Quarter 2014 Dividend 7/24/2014 12:57:43 PM
Charles River Laboratories (Massachusetts) To Webcast Investor Meeting 7/24/2014 11:39:45 AM
CorMedix (CRMD) Granted Extension Of NYSE-MKT Listing 7/24/2014 11:05:55 AM
BioAlliance Pharma: Approval Of Onxeo’s Admission To Secondary Listing And Trading On NASDAQ OMX Copenhagen 7/24/2014 10:45:18 AM
Sigma-Aldrich Corporation (SIAL) (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted Eps Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted Eps Guidance To A New Range Of $4.32 To $4.40 7/24/2014 10:22:34 AM
Spherix (SPEX) Schedules Shareholder Update Call 7/24/2014 9:49:45 AM
Allergy Therapeutics plc Release: Notice Of Results And Trading Update 7/24/2014 9:47:28 AM
1234567
//-->